KN026 Clinical Trials
4 recruitingDrug
Phase 32Phase 22
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer
Advanced Breast Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd.36 enrolled1 locationNCT07597629
Recruiting
Phase 3
A Phase III Study of KN026 in Combination With HB1801 as Adjuvant Therapy for Resectable HER2-Positive Breast Cancer
Resectable HER2-positive Breast Cancer
Shanghai JMT-Bio Inc.1,800 enrolled1 locationNCT07441460
Recruiting
Phase 3
A Phase III Study of KN026 in Combination With HB1801 ± Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast Cancer
Early or Locally Advanced HER2-positive Breast Cancer
Shanghai JMT-Bio Inc.520 enrolled1 locationNCT06747338
Recruiting
Phase 2
Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
HER2-positive Locally Advanced Resectable Gastric Cancer
Peking University18 enrolled1 locationNCT06023758